Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIFT: Chidamide + CHOP in Untreated PTCL-TFH
NCT05572983Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by Sun Yat-sen University. Started Sep 2022; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT05572983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05572983.